Biotech Distributor BDI Pharma Achieves 100% Seasonal Flu Vaccine Fulfillment Rate; Sets Sights on 2012-2013 Pre-Book Campaign

Share Article

National Biotech Distributor BDI Pharma successfully concludes 2011-2012 FLU season and begins pre-booking process for next year’s seasonal influenza virus vaccine.

www.securivax.com

Emphasis on the needs of our customer base, promotion of our trade partners and distribution channels, and focus on corporate program management is at the heart of all that we do.

BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of specialty biotherapeutics, achieved a one hundred percent (100%) pre-book fulfillment rate for the 2011-2012 flu vaccine season and announced the launch of the company’s 2012-2013 seasonal flu pre-book program. Pre-booking for next year’s influenza vaccine will begin Monday, October 3rd. Customers will continue to have access to multiple manufacturers with products covering a wide range of age indications and can order 24/7 on BDI’s corporate vaccine web site http://www.securivax.com.    

"Emphasis on the needs of our customer base, promotion of our trade partners and distribution channels, and focus on corporate program management is at the heart of all that we do,” stated Tom Duffy, Director of Wholesaler Relations/Vaccine Portfolio for BDI Pharma. “The success of our flu vaccine program this year has allowed us to immediately turn our focus towards the 2012-2013 campaign."

The continued success of BDI Pharma’s seasonal flu program is further evidence that the customer-centric, solutions-based service model is sought after and embraced in the marketplace. “Our corporate programs are constructed on the foundation of meeting and surpassing end-user needs and the BDI Pharma seasonal flu program is no exception,” explained Duffy.

About BDI Pharma, Inc.

Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent-need delivery. An open-access resource for reference material, educational literature, market data and online ordering, bdipharma.com (ivig.com) has become an industry-renowned point of reference. Proprietary programs for specialty veterinarians -- 4legpharma.com; product consignment -- consignadvantage.com; flu pre-booking and general vaccine ordering -- securivax.com; and purchasing/reward programs -- qoreprogram.com and securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.

BDI Pharma’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brad Davis
Visit website